UPDATED: CARDIOGENICS HOLDINGS INC. ANNOUNCES A RECORD DATE CHANGE FOR ITS DIVIDEND DISTRIBUTION
28 sept. 2021 17h00 HE
|
CardioGenics Holdings Inc.
Caledon, Ontario, Sept. 28, 2021 (GLOBE NEWSWIRE) -- CardioGenics Holdings INC. (OTC PINK: CGNH) announced on September 3, 2021 a record date of September 13, 2021 for its dividend distribution of...
CARDIOGENICS HOLDINGS INC. ANNOUNCES A RECORD DATE CHANGE FOR ITS DIVIDEND DISTRIBUTION
09 sept. 2021 17h00 HE
|
CardioGenics Holdings Inc.
Caledon, Ontario, Sept. 09, 2021 (GLOBE NEWSWIRE) -- CardioGenics Holdings INC. (OTC PINK: CGNH) announced on September 3, 2021 a record date of September 13, 2021 for its dividend distribution of...
CARDIOGENICS HOLDINGS INC. ANNOUNCES LICENSE AGREEMENT AND DIVIDEND DISTRIBUTION
03 sept. 2021 17h20 HE
|
CardioGenics Holdings Inc.
Caledon, Ontario, Sept. 03, 2021 (GLOBE NEWSWIRE) -- CardioGenics Holdings Inc. (OTC PINK: CGNH) (the “Company”)announced today that its subsidiary, CardioGenics Inc. (“CardioGenics”), has entered...
USPTO Issues Notice of Allowance in Connection With CardioGenics' Self-Metering Cartridge Patent Application
17 févr. 2015 09h00 HE
|
CardioGenics Holdings Inc.
MISSISSAUGA, Ontario, Feb. 17, 2015 (GLOBE NEWSWIRE) -- CardioGenics Holdings Inc. (OTCQB:CGNH), developer of the ultra-sensitive QL Care™ analyzer, an immunoassay point-of-care analyzer, and...
CardioGenics Announces Appointment of New Director
12 janv. 2015 16h30 HE
|
CardioGenics Holdings Inc.
MISSISSAUGA, Ontario, Jan. 12, 2015 (GLOBE NEWSWIRE) -- CardioGenics Holdings Inc. (OTCQB:CGNH), developer of the ultra-sensitive QL Care™ analyzer, an immunoassay point-of-care analyzer, and...
CORRECTING AND REPLACING -- CardioGenics Announces $1.3 Million Private Placement to European Investors
12 juin 2014 17h00 HE
|
CardioGenics Holdings Inc.
MISSISSAUGA, Ontario, June 12, 2014 (GLOBE NEWSWIRE) -- Please replace the release with the following corrected version due to an incorrect date in the last paragraph of the release, which should read...
CardioGenics Announces $1.3 Million Private Placement to European Investors
12 juin 2014 10h04 HE
|
CardioGenics Holdings Inc.
MISSISSAUGA, Ontario, June 12, 2014 (GLOBE NEWSWIRE) -- CardioGenics Holdings Inc. (OTCBB:CGNH), developer of the QL Care™ analyzer, an ultra-sensitive immunoassay point-of-care analyzer, and...
CardioGenics Announces Commencement of Beta-Site Testing
21 août 2013 09h00 HE
|
CardioGenics Holdings Inc.
Beta-Site Testing of the Company's QL Care™ Analyzer and Troponin-I Test Begins in Two Hospitals
MISSISSAUGA, Ontario, Aug. 21, 2013 (GLOBE NEWSWIRE) -- CardioGenics Holdings Inc....
CardioGenics Announces Schedule for Beta-Site Testing
10 juil. 2013 09h00 HE
|
CardioGenics Holdings Inc.
MISSISSAUGA, Ontario, July 10, 2013 (GLOBE NEWSWIRE) -- CardioGenics Holdings Inc. (OTCBB:CGNH), developer of the ultra-sensitive QL Care™ analyzer, an immunoassay Point-Of-Care analyzer, and...